Synthetic Communications · 2019 · 22 citations · 45 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryStructure-activity RelationshipsChemical Library DesignLigand-based DesignMolecular DockingPotency OptimizationProtein-ligand DockingStructure-activity Relationship Analysis1, 3-Dipolar CycloadditionClick ChemistryClick Chemistry FunctionalizationDocking-based Drug DesignMedicinal Chemistry ApplicationsMycobacterium Tuberculosis InfectionTethered AnaloguesTuberculosis Drug Development
In search of more potent new antitubercular agents, a library of novel piperazine tethered dimeric 1,2,3-triazoles were designed by assembling 1,2,3-triazoles and piperazine in a single molecular architectural framework. The titled compounds (3a–m) were synthesized by 1,3-dipolar cycloaddition of 1,4-di(prop-2-yn-1-yl)piperazine (1) and various azides (2a–m) using click chemistry approach with good yields. All the synthesized compounds (3a–m) have been screened for their in vitro antitubercular, antifungal and antioxidant activities against their respective strains. Among them, 3b, 3d, and 3i have revealed promising antitubercular activity against Mycobacterium tuberculosis (Mtb) H37Rv with MIC 12.5 µg/mL. Molecular docking results provided well-clustered solutions to the mode of binding for these molecules into the active site of Mtb enoyl reductase (InhA). In addition to this, most of synthesized compounds were found to have potential antifungal as well as antioxidant activity.
45
Scott G. Franzblau, Richard Witzig, James C. McLaughlin et al. · Journal of Clinical Microbiology · 1998 · 951 citations · Full text
Rate-Limited Steps of Human Oral Absorption and QSAR Studies
Yuan H. Zhao, Michael H. Abraham, Joelle Le et al. · Pharmaceutical Research · 2002 · 707 citations
Catherine Vilchèze, Héctor R. Morbidoni, Torin R. Weisbrod et al. · Journal of Bacteriology · 2000 · 278 citations · Full text